Profile

Bafna Pharmaceuticals forayed into the pharmaceutical manufacturing industry, way back in 1981. The consistent drive and determination of our CMD to expand our horizons resulted in the metamorphosis of Bafna Pharmaceuticals into a Public Limited Company in 1995. Bafna Pharmaceuticals has expanded its operations and set up new and improved manufacturing facilities, in Chennai, India. More than two decades have passed since inception, yet our drive to innovate and exceed expectations remains unsurpassed. Several notable achievements have come our way due to our ceaseless efforts towards ensuring quality, honoring supply commitments, encouraging innovative research and practicing professionalism in operations and management. We were awarded the much-acclaimed WHO GMP in 1995 and have also been accredited with ISO 9001:2008 certifications. The State Pharmaceutical Corporation of Sri Lanka conferred the Best Supplier award to Bafna Pharmaceuticals in 2005. We also have to our credit MHRA, U.K accreditation for our Non Betalactam manufacturing facility located in Grantlyon, Chennai. Earlier this year in January 2010 Bafna Pharmaceuticals was honored with the Gold Quality Excellence award by IDMA (Indian Drug Manufacturers Association). These awards and certifications are a testament to our commitment for quality, innovation and excellence in delivering hi-end finished medical formulations at competitive prices. Bafna Pharmaceuticals has emerged as one of the most competent player in the Contract Research And Manufacturing industry, providing consistent and unmatched service to both domestic and international markets. With state-of-the-art R&D facility, we look ahead to strategic partnerships and global research projects in developing, testing and validating new pharmaceutical formulations. Equipped with the latest infrastructure, trained and experienced personnel and organized management, we could be your trusted partner and facilitator in the global arena of contract research and manufacturing.

Vision
To be recognized as a strategic leader in the global pharmaceutical value chain, through dedicated efforts towards quality management and contract research while maintaining economic viability.

Mission
To achieve INR 5000 million by 2013 by focusing on:
Increased production and marketing of preferred prescription drugs in the global market. Rendering increased contract-manufacturing services and dossier filing in regulated markets, semi regulated markets and RoW market. Operate internationally under the Bafna brand with offices located in emerging and established global markets, by adequately rewarding those who are part of our enterprise.

Future Plans
To achieve a well rounded presence across the Pharma value chain. To focus on generic product developments. To increase operations in regulated markets of Europe, UK, USA (ANDA) and Australia. To metamorphose into a highly respectable leading global brand. To be at the forefront of research and innovation. To operate internationally with manufacturing facilities and offices & marketing teams based in different countries. To undertake contract analysis and research for regulated players. Engender new product development for the domestic market. CTD dossier filing for regulated & semi-regulated global markets. Strictly ensure professionalism at the core of operations. Engender new product development for the domestic market.

Values
Wellness beyond boundaries through
Engendering effective medicines to improve the quality of life, worldwide. An unflinching commitment to ensuring employees safety, enhancing efforts in the arena of corporate social responsibility. Abide by the Corporate Governance Systems & Policies. Implementing environment friendly practices across all manufacturing facilities. To adhere to a moral code of ethics in all business operations. Empowering employees, driving ownership.

Board of Directors
Chairman & Managing Director

MR. BAFNA MAHAVEER CHAND - Chairman and Managing Director aged 49 years, has over three decades of experience in the pharmaceutical industry. A doyen in the industry with in-depth know-how and expertise of all the faculties & operations of the industry. With his sole diligence and vision only, the company has achieved this height from a Limited company in 1995, to the accreditation of Grantlyon facility with UK-MHRA and to the listing of the company in BSE during 2008. His expertise in institutional supplies, supply contracts of the central government & several State Governments of India, the Contract Manufacturing deal from M/s Croslands, Best Supplier award from the Government of Sri Lanka, 336 product licenses, 80 product registrations globally, round the year export to prestigious Regulated Markets, and Emerging markets, contract manufacturing deal from Johnson and Johnson ltd, Gold Quality Excellence Award 2009, setting up the State of the art R&D center and receiving the National Level Entrepreneurship Excellence award in 2010 are just a few glimpses of His success sojourn, at BAFNA.

Directors
Mr. Paras Bafna is the Executive Director in-charge of the Madhavaram manufacturing facility. His astute thinking and management skills are largely responsible for the smooth functioning of this facility. His innate understanding of emerging pharmaceutical market trends has helped us to advance technically and innovatively. Mr. V. Rajamani is a greatly experienced and highly qualified member of the group, specialsing in Financial Management and Company Accounts. Prior to joining Bafna Pharma, he has served as the Company Secretary & Chief Vigilance Officer of Manganese Ore India Ltd at Nagpur. He has acted as Additional/General Manager (co-ordination) and as the Director of M/s Neyveli Lignite Corporation in Tamilnadu. And presently he is engaged as a consultant Director of M/s Morgan Industries Ltd. in Chennai. He possesses over 25 years of service experience in the financial departments of various government establishments. Mr. A. Sahasranaman is a director par excellence; he is a top-level bureaucrat, a research scholar and an accomplished author. Having completed his Masters in Economics, he subsequently joined the Indian

Administrative Service, Jammu & Kashmir Cadre and served from 1973 1996 under several strategic posts. Apart from this he reserves the distinction for having acted as the Executive Director, Council for Leather Exports Chennai. He has lent his expertise to UNDP - Dept. of Industrial Policy & Promotion, Govt. of India. He resumed his tryst with Jammu & Kashmir by accepting an invitation by the state government to serve as the Principal Secretary, Dept. of Industries and Commerce from 2003 2005. Since July 2002, he is serving as the Honorary Director of Indian Leather Industry Foundation, Chennai chapter. In addition to his professional legacy, he is also a renowned author of several books and articles pertaining to the development & promotion of small-scale industries in India. Mr. R. Dwarakanathan possesses a Post Graduate Honors in Arts from Madras University and an MBA Degree from Wichita State University, Kansas, USA. Also, he has to his credit CAIIB, Diploma in Industrial Finance & Co-operation. His professional career began when he joined the State Bank of India. Over a period of time his dedication and managerial capabilities helped him scale-up to several high posts. Since his retirement in 2000, he is serving as a senior faculty in Loyola Institute of Business Administration, Chennai. In the course of his professional career he has specialized in various areas such as Financial Management, Corporate Credit, Foreign Exchange, Organizational Development, Inspection & Management Audit and finally Rehabilitation of sick units. Mr. U. Sunil Bafna is a dynamic, young professional leader looking to steer the company into new horizons in the days to come. He is a Graduate in Corporate Secretaryship from Madras University; later on he completed a specialized course in Financial Management. He brings with him over 15 years of experience matters of finance planning and management.

Quality Policies
Guarantying quality assurance, reliability and effectiveness across all our product segments is both the obligation and pre-requisite at Bafna Pharmaceuticals.

Our main objectives are:

Enhancing the quality and efficacy in all our medical formulations. To achieve and maintain consistency in quality. Ensuring consistent efforts towards training and skill development of all our employees to meet GMP norms. Committed to make Quality a way of life regardless of commercial consequences. Assured practices and process focusing on employee safety, security and welfare. To adopt, adhere and promote environment friendly practices and processes.

Grantlyon Facility
Our Custom Pharmaceutical Services & Solutions (CPSS) expertise serves several leading and emerging pharmaceutical companies. Our wide spread experience in contract research and contract manufacturing, technological strength, the stringent quality policies we employ and our professional approach has enabled us to emerge as one of the preferred CPSS players from India. And a partner-ofchoice to innovators, offering top-end technical expertise, tailor-made pharmaceutical solutions and a track record of bringing process innovations to the market quickly, efficiently and economically. We have the capability to supply both small-scale clinical trial quantities and commercial-scale requirements. Our end-to-end services and competitive pricing offers a compelling value proposition to our global customers. We aim to be the preferred partner for innovator companies by providing a complete range of services that are necessary to take their innovations to the market with greater speed, efficiency and lower capital expenditures.

Key instruments used in our production and quality control:

PRODUCTION Fluid Bed Processor Rapid Mixer Granulator Fluid Bed Drier Material Transfer System Compression Machine, 45 stations and 27 stations Automatic Capsule Filling Machine Automatic Coating Machine Blister Packing Machine / ALU ALU, Triplex with Jeckson Camera USA Strip Packing Machine Auto Cartonator with QUALITY CONTROL Dedicated Microbiology laboratory with dedicated AHU. HPLCs sampler detectors) GC head space with auto sampler FTIR UV spectrophotometer Dissolution apparatus Stability Chambers as per ICH guidelines with auto UTILITIES HVAC system comprising AHUs. 7 FDV ventilators. Chiller, Boiler, Compresser (oil free), Generator etc. Online Nitrogen Systematic of 22

(UV&PDA

Jeckson Camera USA

Bafna Pharmaceuticals ltd committed to reducing their carbon footprint and in general any harm that their work may have on the local and regional environment. Our green strategy and procedures are designed to make all employees, visitors and suppliers aware of their actions and contributions that may make an impact on the environment. It is our intention to operate our production in an as environmentally friendly way as we can, and with our ISO 9001:2008 facility we strive to do the same. MISUSE OF THE 3 PS IS HIGHLY DISCOURAGED AND

ALL STEPS AND MEASURES ARE TAKEN TO USE THEM OPTIMALLY AND WISELY.

Bafna Pharmaceuticals ltd s Green Policy also include the planting of trees and plants in our facility, neighborhood and other appropriate places. We have a unique policy of inviting our customers, guests and higher authorities to plant trees in our premises thus encouraging a greener environment .Our TEAM also does the needful in their area and preach the importance the green policy.